36 Lipitor Lawsuit Claims Removed to West Virginia Federal Court in October as Plaintiffs File Second Request for Multidistrict Litigation
More than 30 new Lipitor lawsuit filings have been added to a federal docket handling cases over the cholesterol-lowering statin after being filed in West Virginia state court, according to court documents.
As per recent records, a total of 36 new claims alleging new-onset diabetes caused by the medication have been removed from the proceeding and are now pending in the U.S. District Court, Southern District of West Virginia. These lawsuits, which allege the association between Lipitor and diabetes, were filed in McDowell County Civil Court between October 10th and October 14th. Court documents indicate that 14 similar actions were filed in September by plaintiffs from West Virginia, New York and North Carolina. According to their complaint, “Lipitor is associated with, and cases, an increased risk of type 2 diabetes and/or blood glucose levels diagnostic for type 2 diabetes. Lipitor is also associated with, and causes an increased risk of heart disease, blindness, neuropathy, kidney disease and other dangerous conditions,” lawyers added.
Plaintiffs Motion to Create Federal Lipitor Lawsuit Multidistrict Litigation
Despite a growing litigation of claims filed by plaintiffs allegedly injured by the statin, Lipitor lawsuits have not been centralized in a federal multidistrict litigation. On October 10th, a motion to create a single federal proceeding for related claims was filed with the U.S. Judicial Panel on Multidistrict Litigation (JPML). In the request, the plaintiff noted that 62 Lipitor lawsuits were pending in 21 federal courts. Earlier this year, a separate group of plaintiffs requested that a single federal proceeding be created, but was denied by the Panel. At the time, 24 Lipitor lawsuits had been filed in the U.S., which they said was not enough to establish a multidistrict litigation.
Concerns surrounding Lipitor have grown steadily over the past year. In February 2012, Pfizer was ordered by the U.S. Food and Drug Administration (FDA) to adjust the medication’s labeling to include the risk for new-onset Type 2 diabetes after it was found that post-menopausal women may run an increased risk for developing the disease. These findings were published in JAMA: Internal Medicine.
In May 2013, a report from the British Medical Journal revealed an association between Lipitor and diabetes. Patients taking Lipitor were 22 percent more likely to develop diabetes, researchers said.
Did You Develop Diabetes After Taking Lipitor? Call a Lipitor Lawyer Today.
Patients who allegedly developed new-onset Type 2 diabetes as a result of the cholesterol-lowering statin may be eligible to seek compensation for their injuries. File a Lipitor lawsuit with an attorney at Bernstein Liebhard LLP today at (877) 779-1414.